HOXA5 and PBX1

  • Number of citations of the paper that reports this interaction (PMID 8657138)
  • 31
  • Data Source:
  • HPRD (in vivo)

HOXA5

PBX1

Gene Name homeobox A5 pre-B-cell leukemia homeobox 1
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 11 interactors: CDX4 DDIT3 FOXA2 FOXO1 GTF2A1L MEIS1 PBX1 PRMT6 SMAD1 TWIST1 ZNF408 24 interactors: CREBBP HOXA1 HOXA10 HOXA5 HOXA9 HOXB1 HOXB7 HOXB8 HOXD10 HOXD4 HOXD9 KAT2A MDM2 MEIS1 MEIS2 MYH10 NEDD4L NR3C1 PAX6 PBX2 PDX1 PKNOX1 POU2F1 SMARCD3
Entrez ID 3202 5087
HPRD ID 00840 08889
Ensembl ID ENSG00000106004 ENSG00000185630
Uniprot IDs P20719 A8K5V0 H0YLB0 P40424 Q53YC7
PDB IDs 1B72 1PUF
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aberrant  abilities  abstract  arrests  committed  depending  drives  erythrocyte  erythroid  erythropoiesis  expanding  g0  hsc  hscs  inappropriate  lineage  modifies  mpps  multipotency  multipotent  pool  predominance  preferentially  progenitor  progenitors  renewal  seq  shrinks  sustain 
4th  addressed  alls  bmt  bristol  characterizing  clonospecific  confirmation  cure  dek  e2a  igh  immunoglobulin  issues  leukaemia  lymphoblastic  myelogenous  offers  opportunity  presumably  purposes  quantitate  rara  rearrangements  tcr  took  truly  uk  workshop 
Tagcloud (Difference) ?
aberrant  abilities  abstract  arrests  committed  depending  drives  erythrocyte  erythroid  erythropoiesis  expanding  g0  hsc  hscs  inappropriate  lineage  modifies  mpps  multipotency  multipotent  pool  predominance  preferentially  progenitor  progenitors  renewal  seq  shrinks  sustain 
4th  addressed  alls  bmt  bristol  characterizing  clonospecific  confirmation  cure  dek  e2a  igh  immunoglobulin  issues  leukaemia  lymphoblastic  myelogenous  offers  opportunity  presumably  purposes  quantitate  rara  rearrangements  tcr  took  truly  uk  workshop 
Tagcloud (Intersection) ?